Ixazomib treatment of iga multiple myeloma with hyperviscosity syndrome

HIGHLIGHTS

• who: Henk-Jan Boiten from the Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands Department of Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands , have published the Article: Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome, in the Journal: (JOURNAL)
• what: The findings from the present case report have shown that IgA-k MM can clinically manifest as HVS with cardiopulmonary symptoms without the other classic signs of HVS, including mucosal bleeding and visual and neurologic abnormalities.
• future: No clinical trials have . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.